35386539|t|Expression of Recombinant Insulin-Like Growth Factor-Binding Protein-3 Receptor in Mammalian Cell Line and Prokaryotic (Escherichia coli) Expression Systems.
35386539|a|Background: Insulin-like growth factor binding protein-3 receptor (IGFBP-3R) (Transmembrane protein 219 [TMEM219]) binds explicitly to IGFBP-3 and exerts its apoptotic and autophagy signalling pathway. Constructing a Henrietta Lacks (HeLa) h6-TMEM219 cell characterize the therapeutic potent of TMEM219 that could interrupt the IGFBP-3/TMEM219 pathway, in cancer treatment and destructive cell illnesses such as diabetes and Alzheimer's. Materials and Methods: First, to develop stable overexpressed HeLa h6-TMEM219 cells, and Escherichia coli BL21 (DE3) with high IGFBP-3R expression, the purchased pcDNA3.1-h6-TMEM219 plasmid was transformed and integrated using CaCl2 and chemical transfection reagents, respectively. The pcDNA3.1-h6-TMEM219 transfection and protein expression was evaluated by the polymerase chain reaction (PCR), western blotting, and flow cytometry. Following the induction of h6-TMEM219 expression, a protein was purified using Ni-NTA chromatography and evaluated by the sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). Results: The 606 base pairs sequence in PCR outcomes confirmed successful pcDNA3.1-h6-TMEM219 transformation in E. Coli BL21 and integration into the HeLa genome. The analysis of protein samples from induced E. Coli BL21 and purified protein demonstrate a band of approximately 22 kDa on SDS-PAGE. Moreover, besides western blot analysis, flow cytometry findings illustrate approximately 84% of transfected HeLa cells (HeLa h6-TMEM219) overexpressed h6-TMEM219 on their surface. Conclusion: We designed a new experiment in the h6-TMEM219 expression procedure in both eukaryotic and prokaryotic hosts. All of our results confirm appropriate transformation and transfection and importantly, approve h6-TMEM 219 membrane expression. Finally, the HeLa h6-TMEM219 cells and the newly purified h6-TMEM219 leverage new studies for molecular diagnostic studies and characterize the therapeutic agents against IGFBP-3/TMEM219 signalling pathway in devastating illnesses in vitro and in vivo.
35386539	26	79	Insulin-Like Growth Factor-Binding Protein-3 Receptor	Gene	124446
35386539	120	136	Escherichia coli	Species	562
35386539	170	223	Insulin-like growth factor binding protein-3 receptor	Gene	124446
35386539	225	233	IGFBP-3R	Gene	124446
35386539	236	261	Transmembrane protein 219	Gene	124446
35386539	263	270	TMEM219	Gene	124446
35386539	293	300	IGFBP-3	Gene	3486
35386539	392	396	HeLa	CellLine	CVCL:0030
35386539	398	400	h6	CellLine	CVCL:KB96
35386539	401	408	TMEM219	Gene	124446
35386539	453	460	TMEM219	Gene	124446
35386539	486	493	IGFBP-3	Gene	3486
35386539	494	501	TMEM219	Gene	124446
35386539	514	520	cancer	Disease	MESH:D009369
35386539	570	578	diabetes	Disease	MESH:D003920
35386539	583	594	Alzheimer's	Disease	MESH:D000544
35386539	658	665	HeLa h6	CellLine	CVCL:0030
35386539	666	673	TMEM219	Gene	124446
35386539	685	712	Escherichia coli BL21 (DE3)	Species	469008
35386539	723	731	IGFBP-3R	Gene	124446
35386539	767	769	h6	CellLine	CVCL:KB96
35386539	770	777	TMEM219	Gene	124446
35386539	823	828	CaCl2	Chemical	MESH:D002122
35386539	892	894	h6	CellLine	CVCL:KB96
35386539	895	902	TMEM219	Gene	124446
35386539	1061	1068	TMEM219	Gene	124446
35386539	1110	1116	Ni-NTA	Chemical	-
35386539	1153	1176	sodium dodecyl sulphate	Chemical	MESH:D012967
35386539	1213	1216	SDS	Chemical	MESH:D012967
35386539	1307	1309	h6	CellLine	CVCL:KB96
35386539	1310	1317	TMEM219	Gene	124446
35386539	1336	1348	E. Coli BL21	Species	511693
35386539	1374	1378	HeLa	CellLine	CVCL:0030
35386539	1432	1444	E. Coli BL21	Species	511693
35386539	1512	1515	SDS	Chemical	MESH:D012967
35386539	1631	1635	HeLa	CellLine	CVCL:0030
35386539	1643	1650	HeLa h6	CellLine	CVCL:0030
35386539	1651	1658	TMEM219	Gene	124446
35386539	1677	1684	TMEM219	Gene	124446
35386539	1754	1761	TMEM219	Gene	124446
35386539	1967	1974	HeLa h6	CellLine	CVCL:0030
35386539	1975	1982	TMEM219	Gene	124446
35386539	2012	2014	h6	CellLine	CVCL:KB96
35386539	2015	2022	TMEM219	Gene	124446
35386539	2125	2132	IGFBP-3	Gene	3486
35386539	2133	2140	TMEM219	Gene	124446
35386539	Association	MESH:D003920	124446
35386539	Association	MESH:D009369	3486
35386539	Association	MESH:D002122	124446
35386539	Negative_Correlation	124446	3486
35386539	Association	MESH:D000544	124446
35386539	Association	MESH:D009369	124446

